[go: up one dir, main page]

GB201813071D0 - Novel therapeutic use - Google Patents

Novel therapeutic use

Info

Publication number
GB201813071D0
GB201813071D0 GBGB1813071.6A GB201813071A GB201813071D0 GB 201813071 D0 GB201813071 D0 GB 201813071D0 GB 201813071 A GB201813071 A GB 201813071A GB 201813071 D0 GB201813071 D0 GB 201813071D0
Authority
GB
United Kingdom
Prior art keywords
therapeutic use
novel therapeutic
novel
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1813071.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Artios Pharma Ltd
Original Assignee
Artios Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Artios Pharma Ltd filed Critical Artios Pharma Ltd
Priority to GBGB1813071.6A priority Critical patent/GB201813071D0/en
Publication of GB201813071D0 publication Critical patent/GB201813071D0/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/502—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
GBGB1813071.6A 2018-08-10 2018-08-10 Novel therapeutic use Ceased GB201813071D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB1813071.6A GB201813071D0 (en) 2018-08-10 2018-08-10 Novel therapeutic use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1813071.6A GB201813071D0 (en) 2018-08-10 2018-08-10 Novel therapeutic use

Publications (1)

Publication Number Publication Date
GB201813071D0 true GB201813071D0 (en) 2018-09-26

Family

ID=63667014

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1813071.6A Ceased GB201813071D0 (en) 2018-08-10 2018-08-10 Novel therapeutic use

Country Status (1)

Country Link
GB (1) GB201813071D0 (en)

Similar Documents

Publication Publication Date Title
SG11202104461XA (en) Therapeutic methods
GB201820166D0 (en) Therapeutic agents
GB201820165D0 (en) Therapeutic agents
IL277336A (en) Combination therapy
GB201804255D0 (en) Macrophage-based therapy
SG11202103253YA (en) Therapeutic compounds
GB201805453D0 (en) Novel use
GB201819853D0 (en) Therapy
GB201805816D0 (en) Therapeutic agents
IL280729A (en) Combination therapy
IL279908A (en) Combination therapy
GB201808150D0 (en) Therapeutic compounds
GB201700526D0 (en) Therapeutic use
SG11202101518QA (en) Combination therapy
GB201816554D0 (en) Novel compounds and therapeutic uses thereof
GB201816553D0 (en) Novel compounds and therapeutic uses thereof
GB201804098D0 (en) Novel compounds and therapeutic uses thereof
GB201818579D0 (en) New therapy
GB201817385D0 (en) Therapy
GB201814036D0 (en) New therapy
GB201813071D0 (en) Novel therapeutic use
GB201820895D0 (en) Therapy
GB201807147D0 (en) Therapeutic combination
GB201820172D0 (en) Therapeutic agents
GB201820170D0 (en) Therapeutic agents

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)